Ipca Labs

{
  "main_header": {
    "sid": 950228,
    "name": "Ipca Labs",
    "stock_name": "Ipca Labs",
    "full_name": "Ipca Laboratories Ltd",
    "name_url": "stocks-analysis/ipca-labs",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,444.70",
    "chg": -11.3,
    "chgp": "-0.78%",
    "dir": -1,
    "prev_price": "1,456.00",
    "mcapval": "36,652.65 Cr",
    "mcap": "Mid Cap",
    "scripcode": "524494",
    "symbol": "IPCALAB",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE571A01038",
    "curr_date": "Apr 07",
    "curr_time": "",
    "bse_nse_vol": "69.33 k",
    "exc_status": "Active",
    "traded_date": "Apr 07, 2026",
    "traded_date_str": "2026 04 07",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/ipca-labs-950228-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Ipca Laboratories Ltd Technical Momentum Shifts Amid Market Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ipca-laboratories-ltd-technical-momentum-shifts-amid-market-volatility-3935493",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/IpcaLaboratorie_technicaldot_3935493.png",
        "date": "2026-04-07 08:04:23",
        "description": "Ipca Laboratories Ltd, a mid-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend. This change is underscored by a combination of bearish and neutral signals across key technical indicators, reflecting a cautious outlook for investors amid recent price declines and mixed market performance."
      },
      {
        "title": "Ipca Laboratories Ltd Valuation Shifts to Fair Amidst Sector Comparisons",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ipca-laboratories-ltd-valuation-shifts-to-fair-amidst-sector-comparisons-3935135",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/IpcaLaboratorie_valuationdot_3935135.png",
        "date": "2026-04-07 08:01:11",
        "description": "Ipca Laboratories Ltd, a mid-cap player in the Pharmaceuticals & Biotechnology sector, has seen its valuation parameters recalibrated from expensive to fair, reflecting a notable shift in price attractiveness. This adjustment comes amid a broader market context where the stock’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios have moderated relative to historical averages and peer benchmarks, prompting a downgrade in its Mojo Grade from Buy to Hold as of 1 April 2026."
      },
      {
        "title": "Ipca Laboratories Declines 6.17% Amid Valuation and Technical Shifts: 5 Key Factors This Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ipca-laboratories-declines-617-amid-valuation-and-technical-shifts-5-key-factors-this-week-3931997",
        "imagepath": "",
        "date": "2026-04-04 15:00:03",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>30 Mar:</strong> Upgraded to Buy on strong technicals and financials</p>\n                    <p><strong>30 Mar:</strong> Technical momentum signals bullish outlook</p>\n                    <p><strong>30 Mar:</strong> Valuation shifts to very expensive</p>\n                    <p><strong>1 Apr:</strong> Intraday low hit amid price pressure</p>\n                    <p><strong>2 Apr:</strong> Downgraded to Hold amid valuation and technical concerns</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,583.65</div></div>\n                    <div class=\"stat-item\"><..."
      },
      {
        "title": "Ipca Laboratories Ltd Downgraded to Hold Amid Valuation and Technical Concerns",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/ipca-laboratories-ltd-downgraded-to-hold-amid-valuation-and-technical-concerns-3929650",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/IpcaLaboratorie_mojoScore_3929650.png",
        "date": "2026-04-02 08:22:44",
        "description": "Ipca Laboratories Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Buy to Hold as of 1 April 2026. This adjustment reflects a nuanced shift across four critical parameters: quality, valuation, financial trend, and technical indicators. Despite strong long-term returns and solid financial performance, evolving market dynamics and valuation concerns have tempered investor enthusiasm."
      },
      {
        "title": "Ipca Laboratories Ltd Hits Intraday Low Amid Price Pressure on 1 April 2026",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ipca-laboratories-ltd-hits-intraday-low-amid-price-pressure-on-1-april-2026-3929305",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/IpcaLaboratorie_priceRelatedfactors_3929305.png",
        "date": "2026-04-01 14:46:01",
        "description": "Ipca Laboratories Ltd experienced a notable intraday decline on 1 Apr 2026, touching a low of Rs 1,514.1, down 5.55% from its previous close. The stock underperformed its sector and broader market indices, reflecting immediate selling pressure and a shift in market sentiment."
      },
      {
        "title": "Ipca Laboratories Upgraded to Buy on Strong Technicals and Financial Performance",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/ipca-laboratories-upgraded-to-buy-on-strong-technicals-and-financial-performance-3923525",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/IpcaLaboratorie_mojoScore_3923525.png",
        "date": "2026-03-30 08:07:16",
        "description": "Ipca Laboratories Ltd has seen its investment rating upgraded from Hold to Buy, reflecting improvements across technical indicators, valuation metrics, financial trends, and overall quality. The pharmaceutical company’s robust quarterly results, consistent returns, and positive market momentum have contributed to this enhanced outlook, despite a valuation that now classifies it as very expensive relative to peers."
      },
      {
        "title": "Ipca Laboratories Ltd Technical Momentum Shifts Signal Bullish Outlook",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ipca-laboratories-ltd-technical-momentum-shifts-signal-bullish-outlook-3923433",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/IpcaLaboratorie_technicaldot_3923433.png",
        "date": "2026-03-30 08:02:23",
        "description": "Ipca Laboratories Ltd has demonstrated a notable shift in technical momentum, with key indicators signalling a transition from mildly bullish to a more confident bullish stance. This change is underscored by improvements in moving averages, Bollinger Bands, and MACD readings, suggesting growing investor confidence amid a strong price performance that outpaces the broader market."
      },
      {
        "title": "Ipca Laboratories Ltd Valuation Shifts Signal Changing Price Attractiveness",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ipca-laboratories-ltd-valuation-shifts-signal-changing-price-attractiveness-3923354",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/IpcaLaboratorie_valuationdot_3923354.png",
        "date": "2026-03-30 08:01:38",
        "description": "Ipca Laboratories Ltd has experienced a notable shift in its valuation parameters, moving from an expensive to a very expensive rating, reflecting evolving market perceptions and price attractiveness. Despite this, the company’s robust financial performance and strong returns relative to the Sensex continue to underpin its Buy-grade status, signalling confidence among investors in the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Ipca Laboratories Ltd is Rated Buy",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/ipca-laboratories-ltd-is-rated-buy-3922732",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/IpcaLaboratorie_mojoScore_3922732.png",
        "date": "2026-03-29 10:10:26",
        "description": "Ipca Laboratories Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 27 March 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 29 March 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance."
      }
    ],
    "total": 938,
    "sid": "950228",
    "stock_news_url": "https://www.marketsmojo.com/news/ipca-laboratories-950228"
  },
  "announcements": [
    {
      "details": "IPCA Laboratories Limited has submitted to the Exchange a copy of Disclosure of Related Party Transactions pursuant to Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.",
      "source": "NSE",
      "caption": "IPCA Laboratories Limited - Other General Purpose",
      "datetime": "27-Nov-2019"
    },
    {
      "details": "IPCA Laboratories Limited has informed the Exchange regarding 'Update on US FDA'.",
      "source": "NSE",
      "caption": "IPCA Laboratories Limited - Updates",
      "datetime": "26-Nov-2019"
    },
    {
      "details": "IPCA Laboratories Limited has informed the Exchange regarding ' a Conference Call to discuss the Company's Q2 FY20 earnings and business update will be held on Friday, 8th November, 2019 at 11.00 hrs IST'.",
      "source": "NSE",
      "caption": "IPCA Laboratories Limited - Updates",
      "datetime": "04-Nov-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Ipca Laboratories Ltd has declared <strong>200%</strong> dividend, ex-date: 05 Aug 25",
          "dt": "2025-08-05",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Ipca Laboratories Ltd has announced <strong>1:2</strong> stock split, ex-date: 10 Jan 22",
          "dt": "2022-01-10",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Ipca Laboratories Ltd Technical Momentum Shifts Amid Market Volatility

2026-04-07 08:04:23

Ipca Laboratories Ltd, a mid-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend. This change is underscored by a combination of bearish and neutral signals across key technical indicators, reflecting a cautious outlook for investors amid recent price declines and mixed market performance.

Read full news article

Ipca Laboratories Ltd Valuation Shifts to Fair Amidst Sector Comparisons

2026-04-07 08:01:11

Ipca Laboratories Ltd, a mid-cap player in the Pharmaceuticals & Biotechnology sector, has seen its valuation parameters recalibrated from expensive to fair, reflecting a notable shift in price attractiveness. This adjustment comes amid a broader market context where the stock’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios have moderated relative to historical averages and peer benchmarks, prompting a downgrade in its Mojo Grade from Buy to Hold as of 1 April 2026.

Read full news article

Ipca Laboratories Declines 6.17% Amid Valuation and Technical Shifts: 5 Key Factors This Week

2026-04-04 15:00:03

Key Events This Week

30 Mar: Upgraded to Buy on strong technicals and financials

30 Mar: Technical momentum signals bullish outlook

30 Mar: Valuation shifts to very expensive

1 Apr: Intraday low hit amid price pressure

2 Apr: Downgraded to Hold amid valuation and technical concerns

Week Open

Rs.1,583.65

<...

Read full news article

Ipca Laboratories Ltd Downgraded to Hold Amid Valuation and Technical Concerns

2026-04-02 08:22:44

Ipca Laboratories Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Buy to Hold as of 1 April 2026. This adjustment reflects a nuanced shift across four critical parameters: quality, valuation, financial trend, and technical indicators. Despite strong long-term returns and solid financial performance, evolving market dynamics and valuation concerns have tempered investor enthusiasm.

Read full news article

Ipca Laboratories Ltd Hits Intraday Low Amid Price Pressure on 1 April 2026

2026-04-01 14:46:01

Ipca Laboratories Ltd experienced a notable intraday decline on 1 Apr 2026, touching a low of Rs 1,514.1, down 5.55% from its previous close. The stock underperformed its sector and broader market indices, reflecting immediate selling pressure and a shift in market sentiment.

Read full news article

Ipca Laboratories Upgraded to Buy on Strong Technicals and Financial Performance

2026-03-30 08:07:16

Ipca Laboratories Ltd has seen its investment rating upgraded from Hold to Buy, reflecting improvements across technical indicators, valuation metrics, financial trends, and overall quality. The pharmaceutical company’s robust quarterly results, consistent returns, and positive market momentum have contributed to this enhanced outlook, despite a valuation that now classifies it as very expensive relative to peers.

Read full news article

Ipca Laboratories Ltd Technical Momentum Shifts Signal Bullish Outlook

2026-03-30 08:02:23

Ipca Laboratories Ltd has demonstrated a notable shift in technical momentum, with key indicators signalling a transition from mildly bullish to a more confident bullish stance. This change is underscored by improvements in moving averages, Bollinger Bands, and MACD readings, suggesting growing investor confidence amid a strong price performance that outpaces the broader market.

Read full news article

Ipca Laboratories Ltd Valuation Shifts Signal Changing Price Attractiveness

2026-03-30 08:01:38

Ipca Laboratories Ltd has experienced a notable shift in its valuation parameters, moving from an expensive to a very expensive rating, reflecting evolving market perceptions and price attractiveness. Despite this, the company’s robust financial performance and strong returns relative to the Sensex continue to underpin its Buy-grade status, signalling confidence among investors in the Pharmaceuticals & Biotechnology sector.

Read full news article

Ipca Laboratories Ltd is Rated Buy

2026-03-29 10:10:26

Ipca Laboratories Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 27 March 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 29 March 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

View All News